Multiple pregnancy rate · Subfertile women undergoing assisted reproduction
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
Adverse events per woman · Subfertile women undergoing assisted reproduction
1 finding from 1 review
Response to treatment · heavy menstrual bleeding
Combined oral contraceptive pill probably leads to higher response to treatment compared with placebo (moderate certainty).
1 finding from 1 review
Improvement in MBL (participant assessment) · heavy menstrual bleeding
Combined oral contraceptive pill probably leads to higher improvement in MBL (participant assessment) compared with placebo (moderate certainty).
1 finding from 1 review
Other primary menstrual bleeding and satisfaction outcomes: semi‐objectively assessed menstrual blood loss, participant satisfaction with treatment · heavy menstrual bleeding
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
Adverse events ‐ treatment emergent · heavy menstrual bleeding
Combined oral contraceptive pill probably leads to higher adverse events ‐ Any adverse events (treatment‐emergent) compared with placebo (moderate certainty).
1 finding from 1 review
MBL (mL per cycle) · women with heavy menstrual bleeding
1 finding from 1 review
Proportion of women with no subjective improvement in MBL · women with heavy menstrual bleeding
NSAIDs may leads to lower proportion of women with no subjective improvement in MBL compared with placebo (control) (low certainty).
1 finding from 1 review
Quality of life · women with heavy menstrual bleeding
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
Number of days' bleeding · women with heavy menstrual bleeding
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
Ongoing pregnancy · assisted reproductive technology
It is very uncertain whether nonsteroidal anti‐inflammatory drugs changes ongoing pregnancy compared with placebo/ no treatment (very low certainty).
1 finding from 1 review
Miscarriage · assisted reproductive technology
It is very uncertain whether nonsteroidal anti‐inflammatory drugs changes miscarriage compared with placebo/ no treatment (very low certainty).
1 finding from 1 review
Clinical pregnancy · assisted reproductive technology
Nonsteroidal anti‐inflammatory drugs showed no clear difference in clinical pregnancy compared with placebo/ no treatment (low certainty).
1 finding from 1 review
Ectopic pregnancy · assisted reproductive technology
It is very uncertain whether nonsteroidal anti‐inflammatory drugs changes ectopic Pregnancy compared with placebo/ no treatment (very low certainty).
1 finding from 1 review
Multiple pregnancy · assisted reproductive technology
It is very uncertain whether nonsteroidal anti‐inflammatory drugs changes multiple pregnancy compared with placebo/ no treatment (very low certainty).
1 finding from 1 review
Side effects · assisted reproductive technology
It is very uncertain whether nonsteroidal anti‐inflammatory drugs changes side effects compared with placebo/ no treatment (very low certainty).
1 finding from 1 review
Live birth rate – euthyroid women with anti‐TPO antibodies · subfertile women with euthyroid autoimmune thyroid disease or subclinical hypothyroidism
Thyroxine showed no clear difference in live birth rate – euthyroid women with anti‐TPO antibodies compared with placebo or no treatment (low certainty).
1 finding from 1 review
Adverse events including maternal pregnancy complications, foetal complications and adverse effects of thyroxine · subfertile women with euthyroid autoimmune thyroid disease or subclinical hypothyroidism
Thyroxine led to lower adverse events including maternal pregnancy complications, foetal… compared with placebo or no treatment; GRADE not reported.
1 finding from 1 review
Miscarriage – anti‐TPO antibodies · subfertile women with euthyroid autoimmune thyroid disease or subclinical hypothyroidism
Thyroxine showed no clear difference in miscarriage – anti‐TPO antibodies compared with placebo or no treatment (low certainty).
1 finding from 1 review
Live birth rate per woman · women with polycystic ovary syndrome
Metformin showed no clear difference in live birth rate per woman compared with placebo or no treatment (low certainty).
1 finding from 1 review